Finance

Senarai
500420:BOM
Torrent Pharmaceuticals Ltd
₹4,585.75
-0.44%
(-20.20) 1H
16 Okt, 10:14:08 PG GMT+5:30  ·   INR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 500420...
Buka
₹4,579.80
Tinggi
₹4,619.10
Rendah
₹4,554.00
Permodalan Pasaran
1.74T
Purata volum
9.70K
Volum
1.59K
Dividen
0.83%
Dividen suku tahunan
₹9.50
Tarikh tanpa dividen
29 Mei 2026
Nisbah H/P
73.26
tgi 52 mgu
₹5,249.95
rdh 52 mgu
₹3,511.00
EPS
₹62.60
Syer tertunggak
170.00J
Bilangan pekerja
18K
Buka
₹4,579.80
Tinggi
₹4,619.10
Rendah
₹4,554.00
Permodalan Pasaran
1.74T
Purata volum
9.70K
Volum
1.59K
Dividen
0.83%
Dividen suku tahunan
₹9.50
Tarikh tanpa dividen
29 Mei 2026
Nisbah H/P
73.26
tgi 52 mgu
₹5,249.95
rdh 52 mgu
₹3,511.00
EPS
₹62.60
Syer tertunggak
170.00J
Bilangan pekerja
18K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
Perihal Torrent Pharmaceuticals Ltd
CEO-
Pekerja18.3K
Diasaskan1959
Ibu pejabatAhmedabad, Gujarat, India
Sektor-
Laporan sebelumnyaSemua nilai dalam INR
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam INR
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
33.02B
33.03B
41.97B
49.21B
Kos barangan yang dijual
8.00B
7.99B
10.15B
11.63B
Kos hasil
8.00B
7.99B
10.15B
11.63B
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
6.27B
6.51B
8.48B
8.93B
Belanja kendalian
16.23B
16.22B
23.34B
26.87B
Jumlah belanja kendalian
24.23B
24.21B
33.49B
38.50B
Pendapatan kendalian
8.79B
8.82B
8.48B
10.71B
Pendapatan bukan kendalian lain
-270.00J
-130.00J
794.40J
-120.00J
EBT termasuk item luar biasa
7.91B
8.14B
5.29B
7.33B
EBT tidak termasuk item luar biasa
8.04B
8.24B
5.47B
7.54B
Belanja cukai pendapatan
2.00B
1.79B
1.65B
1.67B
Kadar cukai berkesan
25.28%
21.99%
31.18%
22.78%
Belanja kendalian lain
7.92B
7.65B
9.78B
12.01B
Pendapatan bersih
5.91B
6.35B
3.89B
5.66B
Margin untung bersih
17.90%
19.22%
9.28%
11.50%
Perolehan bagi setiap syer
17.75
19.00
12.85
15.30
Pendapatan faedah dan pelaburan
-
-
384.30J
-
Belanja faedah
-480.00J
-450.00J
-2.36B
-3.05B
Belanja faedah bersih
-480.00J
-450.00J
-1.97B
-3.05B
Caj susut nilai dan pelunasan
2.04B
2.06B
5.08B
5.93B
EBITDA
10.82B
10.69B
11.12B
13.35B
Keuntungan atau kerugian daripada jualan aset
-
-
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google